Moraga, CA, United States of America

Mark A Wechser

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 78(Granted Patents)


Location History:

  • Foster City, CA (US) (2008)
  • Moraga, CA (US) (2009)

Company Filing History:

goldMedal2 out of 832,680 
Other
 patents

Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):

Title: Mark A Wechser: Innovator in Cancer Patient Classification

Introduction

Mark A Wechser, located in Moraga, CA, is a notable inventor with a focus on advancements in healthcare technology. With a total of 2 patents to his name, he has significantly contributed to the field of oncology by developing methodologies for classifying patients with diffuse large B-cell lymphoma.

Latest Patents

Wechser’s latest patents revolve around the classification of patients having diffuse large B-cell lymphoma (DLBCL) based on gene expression. His innovative methods and kits utilize real-time quantitative RT-PCR to measure gene expression values. By correlating these values from a tumor sample with reference expression values from previously identified DLBCL patients, his classification techniques allow for better stratification of patients into distinct groups. These advancements hold the potential to predict overall patient survival, making a meaningful impact in personalized cancer treatment.

Career Highlights

Throughout his career, Wechser has achieved recognition for his contributions to medical technology and cancer research. His work in patenting methodologies that enhance patient classification not only showcases his creativity as an inventor but also underscores the importance of technological innovation in improving patient outcomes in oncology.

Collaborations

Wechser has worked alongside distinguished professionals in the field, including Ronald Levy and Izidore Lossos. These collaborations have helped foster a shared vision in developing innovative tools and techniques designed to further understanding and treatment of cancer.

Conclusion

With a commitment to advancing cancer diagnosis and treatment, Mark A Wechser exemplifies the role of an inventor in the healthcare domain. His work in classifying patients with diffuse large B-cell lymphoma based on gene expression paves the way for more personalized approaches to cancer care, ultimately contributing to the enhancement of patient survival rates.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…